The majority of women with breast cancer are likely to survive for many years after the initial diagnosis and treatment. Unfortunately, long-term disease and treatment-related symptoms, such as chronic pain, can have wide-ranging consequences for health, functioning, and life quality. The purpose of this pilot project is to describe the characteristics of the chronic pain experienced by women with breast cancer who are post-breast cancer surgery with particular emphasis on the description of widespread pain, The specific aims are to: (1) describe characteristics of the chronic pain experienced by women who are post-breast cancer surgery; and (2) compare and contrast the pain characteristics, sensory thresholds, upper body muscle strength and impairment, syndrome impact, health status, and quality of life of women with neuropathic pain only with that of women who meet criteria for fibromyalgia, a specific syndrome of widespread pain. The immediate goal of this pilot project is to test an assessment strategy for characterizing the pain, impairment, and impact. The long term goals are to use the information to support the development of better diagnostic assessments of post-breast cancer surgery pain and the development of innovative early intervention strategies to prevent widespread pain and increase the functioning, health and quality of life of women who have post-breast cancer surgery pain. The study will use a descriptive design in which 30 women, with either post-surgery chronic pain that is limited to the operated side or widespread body pain, will be assessed for descriptions of the pain, muscle strength of the upper extremities, lymphedema, tender points, joint tenderness and swelling, sensory integrity, thermal sensation, health status, and quality of life.

Agency
National Institute of Health (NIH)
Institute
National Institute of Nursing Research (NINR)
Type
Exploratory Grants (P20)
Project #
5P20NR007807-02
Application #
6660143
Study Section
Special Emphasis Panel (ZNR1)
Project Start
2002-09-01
Project End
2003-08-31
Budget Start
Budget End
Support Year
2
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Oregon Health and Science University
Department
Type
DUNS #
009584210
City
Portland
State
OR
Country
United States
Zip Code
97239
Elsea, Collin R; Roberts, Daniel A; Druker, Brian J et al. (2008) Inhibition of p38 MAPK suppresses inflammatory cytokine induction by etoposide, 5-fluorouracil, and doxorubicin without affecting tumoricidal activity. PLoS One 3:e2355
Winters-Stone, Kerri M; Bennett, Jill A; Nail, Lillian et al. (2008) Strength, physical activity, and age predict fatigue in older breast cancer survivors. Oncol Nurs Forum 35:815-21
Nail, Lillian M (2006) Cognitive changes in cancer survivors. Cancer and cancer treatment often cause cognitive deficits, but no guidelines exist for screening or treatment. Am J Nurs 106:48-54
Wood, Lisa J; Nail, Lillian M; Perrin, Nancy A et al. (2006) The cancer chemotherapy drug etoposide (VP-16) induces proinflammatory cytokine production and sickness behavior-like symptoms in a mouse model of cancer chemotherapy-related symptoms. Biol Res Nurs 8:157-69
Wood, Lisa J; Nail, Lillian M; Gilster, April et al. (2006) Cancer chemotherapy-related symptoms: evidence to suggest a role for proinflammatory cytokines. Oncol Nurs Forum 33:535-42
Nail, Lillian M (2006) Cognitive changes in cancer survivors. Cancer Nurs 29:48-54
Fromme, Erik K; Tilden, Virginia P; Drach, Linda L et al. (2004) Increased family reports of pain or distress in dying Oregonians: 1996 to 2002. J Palliat Med 7:431-42
Nail, Lillian M (2004) My get up and go got up and went: fatigue in people with cancer. J Natl Cancer Inst Monogr :72-5
Hickman, Susan E; Tilden, Virginia P; Tolle, Susan W (2004) Family perceptions of worry, symptoms, and suffering in the dying. J Palliat Care 20:20-7